Products
16619 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASML Constant Leverage with ISIN code: CH1290992671 | ASML | Constant Leverage | Short | ― | 882.65 | 0.39 | 0.010 | 0.4 | 1 | -11.36% | 21.88% | -20.41% | 5 Feb. 2024 | |
| Nvidia Constant Leverage with ISIN code: CH1290992705 | Nvidia | Constant Leverage | Long | ― | 173.415 | 0.055 | ― | ― | 1 | 5.77% | -22.54% | -31.25% | 5 Feb. 2024 | |
| Lonza Group Constant Leverage with ISIN code: CH1290992754 | Lonza Group | Constant Leverage | Long | ― | 525.351 | 3.97 | 0.020 | 3.99 | 1 | -1.00% | -2.70% | -10.99% | 5 Feb. 2024 | |
| Lonza Group Constant Leverage with ISIN code: CH1290992762 | Lonza Group | Constant Leverage | Long | ― | 525.351 | 1.02 | 0.010 | 1.03 | 1 | -0.97% | -2.86% | -15.00% | 5 Feb. 2024 | |
| Netflix Constant Leverage with ISIN code: CH1290992796 | Netflix | Constant Leverage | Long | ― | 95.177 | 12.2 | 0.100 | 12.3 | 1 | 0.99% | 3.39% | -56.61% | 5 Feb. 2024 | |
| S&P 500 Constant Leverage with ISIN code: CH1290992812 | S&P 500 | Constant Leverage | Short | ― | 6,756.84 | 0.977 | 0.001 | 0.978 | 1 | -2.50% | 10.77% | -11.66% | 16 Feb. 2024 | |
| Roche Constant Leverage with ISIN code: CH1290992838 | Roche | Constant Leverage | Long | ― | 317.287 | 9.12 | 0.040 | 9.16 | 1 | 1.56% | -4.30% | 1.67% | 16 Feb. 2024 | |
| Barrick Mining Constant Leverage with ISIN code: CH1290992853 | Barrick Mining | Constant Leverage | Long | ― | 43.319 | 15.16 | 0.260 | 15.42 | 1 | -5.66% | 0.07% | 95.87% | 16 Feb. 2024 | |
| Booking Constant Leverage with ISIN code: CH1290992879 | Booking | Constant Leverage | Long | ― | 5,344.19 | 2.88 | 0.190 | 3.07 | 1 | -4.64% | 0.70% | 60.89% | 16 Feb. 2024 | |
| RWE Constant Leverage with ISIN code: CH1290992887 | RWE | Constant Leverage | Long | ― | 43.72 | 2.95 | 0.020 | 2.97 | 1 | -1.99% | 6.12% | -27.34% | 16 Feb. 2024 | |
| Newmont Constant Leverage with ISIN code: CH1290992903 | Newmont | Constant Leverage | Long | ― | 98.289 | 68.87 | 0.430 | 69.3 | 1 | -4.72% | -5.50% | 47.82% | 16 Feb. 2024 | |
| Newmont Constant Leverage with ISIN code: CH1290992911 | Newmont | Constant Leverage | Long | ― | 98.289 | 13.64 | 0.090 | 13.73 | 1 | -6.89% | -8.64% | 63.55% | 16 Feb. 2024 | |
| Meta Platforms Constant Leverage with ISIN code: CH1290992929 | Meta Platforms | Constant Leverage | Short | ― | 653.443 | 0.28 | 0.020 | 0.3 | 1 | -6.67% | -3.45% | -34.88% | 16 Feb. 2024 | |
| Meta Platforms Constant Leverage with ISIN code: CH1290992937 | Meta Platforms | Constant Leverage | Long | ― | 653.443 | 4.16 | 0.070 | 4.23 | 1 | 0.48% | -1.65% | 32.48% | 16 Feb. 2024 | |
| Schneider Electric Constant Leverage with ISIN code: CH1290992945 | Schneider Electric | Constant Leverage | Long | ― | 232 | 0.84 | 0.010 | 0.85 | 1 | 1.20% | -23.64% | -1.18% | 16 Feb. 2024 | |
| PayPal Constant Leverage with ISIN code: CH1290992952 | PayPal | Constant Leverage | Long | ― | 59.155 | 0.012 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 16 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 304.237 | 0.62 | 0.010 | 0.63 | 1 | -3.13% | 26.53% | -25.30% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 304.237 | 0.01 | ― | ― | 1 | 11.11% | 11.11% | 11.11% | 23 Feb. 2024 | |
| DAX Constant Leverage with ISIN code: CH1290993125 | DAX | Constant Leverage | Short | ― | 24,024.8 | 0.179 | 0.001 | 0.18 | 1 | -4.79% | 10.49% | -25.42% | 11 Mar. 2024 | |
| DAX Constant Leverage with ISIN code: CH1290993133 | DAX | Constant Leverage | Short | ― | 24,024.8 | 1.865 | 0.001 | 1.866 | 1 | -2.36% | 5.67% | -13.22% | 11 Mar. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.